연구성과로 돌아가기

2021 연구자 정보 (33 / 1146)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Miura, S.
(Miura, S)
Niigata Canc Ctr Hosp, Dept Internal Med, Niigata, Japan

[JCR상위 1.8] Sequential afatinib (afa) and osimertinib (osi) in patients (pts) with advanced EGFR mutation-positive (EGFRm plus ) NSCLC who acquire the T790M resistance mutation: A non-interventional cohort study (UpSwinG)
[JCR상위 5.1] Sequential Afatinib and Osimertinib in Patients With Advanced EGFRm plus NSCLC and Acquired T790M: The Real-World UpSwinG study
SCIE 1.8 ONCOLOGY
ONCOLOGY;RESPIRATORY SYSTEM
Moon, J.
(Moon, J)
Hanyang Univ, Dept Internal Med, Coll Med, Guri, South Korea

[JCR상위 1.8] The clinical burden in systemic corticosteroid-independent asthmatics with high blood eosinophil counts: COREA cohort in Korea SCIE 1.8 ALLERGY;IMMUNOLOGY
Moon, J. H.
(Moon, JH)
교신저자 Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, 130 Dongdeok Ro, Daegu 41944, South Korea

[JCR상위 1.8] Combination treatment of copanlisib and gemcitabine in relapsed refractory PTCL (COSMOS): an open-label phase I/II trial SCIE 1.8 ONCOLOGY jhmoon@knu.ac.kr;drydb1685@hotmail.com;drydh1685@hotmail.com;
Park, C.
(Park, C)
Inje Univ, Haeundae Paik Hosp, Dept Internal Med, Busan, South Korea

[JCR상위 1.8] The clinical burden in systemic corticosteroid-independent asthmatics with high blood eosinophil counts: COREA cohort in Korea SCIE 1.8 ALLERGY;IMMUNOLOGY
Park, C. S.
(Park, CS)
Inje Univ, Haeundae Paik Hosp, Busan, South Korea

[JCR상위 1.8] eAssociation between nonalcoholic fatty liver disease and the incidence of asthma in adults: results from the korean national health insurance service-national sample cohort (NHIS-NSC) database SCIE 1.8 ALLERGY;IMMUNOLOGY
Park, G. S.
(Park, GS)
Catholic Univ Korea, Coll Med, Dept Pathol, Seoul St Marys Hosp, Seoul, South Korea

[JCR상위 1.8] Combination treatment of copanlisib and gemcitabine in relapsed refractory PTCL (COSMOS): an open-label phase I/II trial SCIE 1.8 ONCOLOGY jhmoon@knu.ac.kr;drydb1685@hotmail.com;drydh1685@hotmail.com;
Popat, S.
(Popat, S)
제1저자 Royal Marsden Natl Hlth Serv Fdn Trust, Lung Unit, London, England
Inst Canc Res, London, England
AAO-1634-2021
Popat, Sanjay
0000-0003-2087-4963
Popat, Sanjay
[JCR상위 1.8] Sequential afatinib (afa) and osimertinib (osi) in patients (pts) with advanced EGFR mutation-positive (EGFRm plus ) NSCLC who acquire the T790M resistance mutation: A non-interventional cohort study (UpSwinG)
[JCR상위 5.1] Sequential Afatinib and Osimertinib in Patients With Advanced EGFRm plus NSCLC and Acquired T790M: The Real-World UpSwinG study
SCIE 1.8 ONCOLOGY
ONCOLOGY;RESPIRATORY SYSTEM
Roh, J.
(Roh, J)
제1저자 Chungnam Natl Univ, Sejong Hosp, Sejong, South Korea

[JCR상위 1.8] eAssociation between nonalcoholic fatty liver disease and the incidence of asthma in adults: results from the korean national health insurance service-national sample cohort (NHIS-NSC) database SCIE 1.8 ALLERGY;IMMUNOLOGY
Saeed, Muhammed
(Saeed, M)
제1저자 교신저자 Khalifa Univ Sci & Technol, Mech Engn Dept, POB 127788, Abu Dhabi, U Arab Emirates R-4401-2019
Saeed, Muhammad
0000-0002-5079-0149
Saeed, Muhammad
[JCR상위 1.8] CFD aided design and analysis of a precooler with zigzag channels for supercritical CO2 power cycle SCIE 1.8 ENERGY & FUELS;MECHANICS;THERMODYNAMICS muhammed.saeed1@ku.ac.ae;
Shin, H-J
(Shin, HJ)
Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea

[JCR상위 1.8] Combination treatment of copanlisib and gemcitabine in relapsed refractory PTCL (COSMOS): an open-label phase I/II trial SCIE 1.8 ONCOLOGY jhmoon@knu.ac.kr;drydb1685@hotmail.com;drydh1685@hotmail.com;
Shin, Y. S.
(Shin, YS)
Ajou Univ, Dept Allergy & Clin Immunol, Sch Med, Suwon, South Korea

[JCR상위 1.8] The clinical burden in systemic corticosteroid-independent asthmatics with high blood eosinophil counts: COREA cohort in Korea SCIE 1.8 ALLERGY;IMMUNOLOGY
Yang, D-H
(Yang, DH)
교신저자 Chonnam Natl Univ, Hwasun Hosp, Dept Internal Med, Med Sch, 322 Seoyang Ro, Hwasun 58128, Jeollanam Do, South Korea

[JCR상위 1.8] Combination treatment of copanlisib and gemcitabine in relapsed refractory PTCL (COSMOS): an open-label phase I/II trial SCIE 1.8 ONCOLOGY jhmoon@knu.ac.kr;drydb1685@hotmail.com;drydh1685@hotmail.com;
Yhim, H-Y
(Yhim, HY)
제1저자 Jeonbuk Natl Univ, Med Sch, Dept Internal Med, Jeonju, South Korea
Jeonbuk Natl Univ, Jeonbuk Natl Univ Hosp, Res Inst Clin Med, Biomed Res Inst, Jeonju, South Korea


[JCR상위 1.8] Combination treatment of copanlisib and gemcitabine in relapsed refractory PTCL (COSMOS): an open-label phase I/II trial SCIE 1.8 ONCOLOGY jhmoon@knu.ac.kr;drydb1685@hotmail.com;drydh1685@hotmail.com;
Yoon, S.
(Yoon, S)
Chungnam Natl Univ, Sejong Hosp, Sejong, South Korea

[JCR상위 1.8] eAssociation between nonalcoholic fatty liver disease and the incidence of asthma in adults: results from the korean national health insurance service-national sample cohort (NHIS-NSC) database SCIE 1.8 ALLERGY;IMMUNOLOGY
Baek, Dong Won, Sr.
(Baek, DW Sr)
제1저자 Kyungpook Natl Univ Hosp, Hematol & Oncol, Daegu, South Korea
Kyungpook Natl Univ Hosp, Hematol Oncol, Daegu, South Korea


[JCR상위 1.9] Multicenter Phase II Study to Evaluate Therapeutic Efficacy of Imatinib Mesylate in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease
[JCR상위 1.9] Development of a New Risk Stratification System for Patients with Newly Diagnosed Multiple Myeloma Using R-ISS and 18F-FDG PET/CT
SCIE 1.9 HEMATOLOGY
페이지 이동: